A team led by Mass General Brigham researchers demonstrated that inebilizumab reduced the risk of symptoms by 87% in patients with the rare affliction known as immunoglobulin G4–related disease (IgG4- ...

Joint pain and arthritis are often used interchangeably, but not all joint pain is associated with arthritis. Joint pain may ...

There are certain phrases that Wachuka Gichohi finds difficult to hear after enduring four years of living with long COVID, ...

Exagen Inc., a leading provider of autoimmune testing, today announced the validation and regulatory submission for approval of new Systemic Lupus Erythematosus (SLE) and rheumatoid arthritis (RA) ...

Researchers found that while some patients showed gut instability, others with stable microbiomes did not progress to ...

Similar percentages of patients with PsA receiving secukinumab vs adalimumab achieved an ACR20 response at 12 weeks.

Sixty-nine-year-old Mary Anne Laporte was diagnosed with knee arthritis 15 years ago. For years, she kept the pain under control with steroid injections and physical therapy, but when she began ...

The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical ...

Objectives Secondary prevention of rheumatoid arthritis (RA) is generally considered potentially impactful because the entire ...

At-risk individuals who progress to rheumatoid arthritis (RA) have a distinctive gut microbial composition, according to a ...